Browsing Tag
Apple Tree Partners
2 posts
Deep Apple Therapeutics signs $812m global deal with Novo Nordisk for oral cardiometabolic drugs
Deep Apple inks up to $812M deal with Novo Nordisk to advance oral GPCR drugs for obesity and metabolic diseases. Explore the science behind the strategy.
June 11, 2025
Alexion Pharmaceuticals to acquire Syntimmune for $1.2bn to boost rare disease drug pipeline
In a significant move within the pharmaceutical industry, Alexion Pharmaceuticals, a leading global biopharma company, has announced its…
September 30, 2018